nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCB1—peripheral nervous system neoplasm	0.306	1	CbGaD
Rilpivirine—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0757	0.136	CbGbCtD
Rilpivirine—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0525	0.0942	CbGbCtD
Rilpivirine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0495	0.0889	CbGbCtD
Rilpivirine—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0323	0.058	CbGbCtD
Rilpivirine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0312	0.0561	CbGbCtD
Rilpivirine—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0301	0.0541	CbGbCtD
Rilpivirine—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0296	0.0532	CbGbCtD
Rilpivirine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0273	0.049	CbGbCtD
Rilpivirine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0273	0.049	CbGbCtD
Rilpivirine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0249	0.0448	CbGbCtD
Rilpivirine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0212	0.0381	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0202	0.0363	CbGbCtD
Rilpivirine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0189	0.034	CbGbCtD
Rilpivirine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0164	0.0294	CbGbCtD
Rilpivirine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0152	0.0273	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0142	0.0255	CbGbCtD
Rilpivirine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0122	0.0219	CbGbCtD
Rilpivirine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0116	0.0209	CbGbCtD
Rilpivirine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0109	0.0195	CbGbCtD
Rilpivirine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0107	0.0192	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00728	0.0131	CbGbCtD
Rilpivirine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00698	0.0125	CbGbCtD
Rilpivirine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0064	0.0115	CbGbCtD
Rilpivirine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00436	0.00784	CbGbCtD
Rilpivirine—Etravirine—ABCB1—peripheral nervous system neoplasm	0.0022	0.697	CrCbGaD
Rilpivirine—Pazopanib—ABCB1—peripheral nervous system neoplasm	0.000959	0.303	CrCbGaD
Rilpivirine—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.000434	0.00325	CcSEcCtD
Rilpivirine—Mental disorder—Tretinoin—peripheral nervous system neoplasm	0.000434	0.00324	CcSEcCtD
Rilpivirine—Mental disorder—Isotretinoin—peripheral nervous system neoplasm	0.000434	0.00324	CcSEcCtD
Rilpivirine—Blood creatinine increased—Cisplatin—peripheral nervous system neoplasm	0.000433	0.00324	CcSEcCtD
Rilpivirine—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.000431	0.00322	CcSEcCtD
Rilpivirine—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.000431	0.00322	CcSEcCtD
Rilpivirine—Depression—Alitretinoin—peripheral nervous system neoplasm	0.000417	0.00312	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Cisplatin—peripheral nervous system neoplasm	0.000416	0.00311	CcSEcCtD
Rilpivirine—Renal failure—Alitretinoin—peripheral nervous system neoplasm	0.000411	0.00307	CcSEcCtD
Rilpivirine—Depression—Vincristine—peripheral nervous system neoplasm	0.000401	0.003	CcSEcCtD
Rilpivirine—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00286	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Etoposide—peripheral nervous system neoplasm	0.000373	0.00279	CcSEcCtD
Rilpivirine—Urinary tract disorder—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.00277	CcSEcCtD
Rilpivirine—Urethral disorder—Alitretinoin—peripheral nervous system neoplasm	0.000368	0.00275	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000367	0.00275	CcSEcCtD
Rilpivirine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00273	CcSEcCtD
Rilpivirine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00273	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000364	0.00272	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000364	0.00272	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000359	0.00269	CcSEcCtD
Rilpivirine—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.000359	0.00268	CcSEcCtD
Rilpivirine—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.000359	0.00268	CcSEcCtD
Rilpivirine—Urinary tract disorder—Vincristine—peripheral nervous system neoplasm	0.000357	0.00267	CcSEcCtD
Rilpivirine—Urethral disorder—Vincristine—peripheral nervous system neoplasm	0.000354	0.00265	CcSEcCtD
Rilpivirine—Infection—Topotecan—peripheral nervous system neoplasm	0.000352	0.00263	CcSEcCtD
Rilpivirine—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.00035	0.00262	CcSEcCtD
Rilpivirine—Infection—Tretinoin—peripheral nervous system neoplasm	0.000349	0.00261	CcSEcCtD
Rilpivirine—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000349	0.00261	CcSEcCtD
Rilpivirine—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000348	0.0026	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00258	CcSEcCtD
Rilpivirine—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000345	0.00258	CcSEcCtD
Rilpivirine—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000345	0.00258	CcSEcCtD
Rilpivirine—Infection—Melphalan—peripheral nervous system neoplasm	0.000345	0.00258	CcSEcCtD
Rilpivirine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000344	0.00258	CcSEcCtD
Rilpivirine—Creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00257	CcSEcCtD
Rilpivirine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00255	CcSEcCtD
Rilpivirine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00255	CcSEcCtD
Rilpivirine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000337	0.00252	CcSEcCtD
Rilpivirine—Inflammation—Epirubicin—peripheral nervous system neoplasm	0.000337	0.00252	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.000337	0.00252	CcSEcCtD
Rilpivirine—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.00246	CcSEcCtD
Rilpivirine—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00244	CcSEcCtD
Rilpivirine—Abnormal dreams—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00242	CcSEcCtD
Rilpivirine—Renal failure—Etoposide—peripheral nervous system neoplasm	0.000321	0.0024	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00239	CcSEcCtD
Rilpivirine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000318	0.00238	CcSEcCtD
Rilpivirine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000318	0.00238	CcSEcCtD
Rilpivirine—Creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.00238	CcSEcCtD
Rilpivirine—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000317	0.00237	CcSEcCtD
Rilpivirine—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.000316	0.00236	CcSEcCtD
Rilpivirine—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.000313	0.00234	CcSEcCtD
Rilpivirine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000313	0.00234	CcSEcCtD
Rilpivirine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000313	0.00234	CcSEcCtD
Rilpivirine—Inflammation—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.00233	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000308	0.00231	CcSEcCtD
Rilpivirine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000308	0.0023	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000306	0.00229	CcSEcCtD
Rilpivirine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000306	0.00229	CcSEcCtD
Rilpivirine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000306	0.00229	CcSEcCtD
Rilpivirine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000306	0.00229	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000304	0.00227	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000304	0.00227	CcSEcCtD
Rilpivirine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000303	0.00227	CcSEcCtD
Rilpivirine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000303	0.00227	CcSEcCtD
Rilpivirine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000302	0.00226	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.0003	0.00224	CcSEcCtD
Rilpivirine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000299	0.00224	CcSEcCtD
Rilpivirine—Abnormal dreams—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00224	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00029	0.00217	CcSEcCtD
Rilpivirine—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000289	0.00216	CcSEcCtD
Rilpivirine—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000289	0.00216	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000287	0.00215	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000287	0.00215	CcSEcCtD
Rilpivirine—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000287	0.00215	CcSEcCtD
Rilpivirine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000285	0.00214	CcSEcCtD
Rilpivirine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00028	0.0021	CcSEcCtD
Rilpivirine—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000278	0.00208	CcSEcCtD
Rilpivirine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000278	0.00208	CcSEcCtD
Rilpivirine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000278	0.00208	CcSEcCtD
Rilpivirine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.00207	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.00206	CcSEcCtD
Rilpivirine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.00203	CcSEcCtD
Rilpivirine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.00198	CcSEcCtD
Rilpivirine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000264	0.00198	CcSEcCtD
Rilpivirine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.00195	CcSEcCtD
Rilpivirine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000259	0.00194	CcSEcCtD
Rilpivirine—Infection—Vincristine—peripheral nervous system neoplasm	0.000255	0.00191	CcSEcCtD
Rilpivirine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000254	0.0019	CcSEcCtD
Rilpivirine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000252	0.00189	CcSEcCtD
Rilpivirine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000252	0.00189	CcSEcCtD
Rilpivirine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000252	0.00188	CcSEcCtD
Rilpivirine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00025	0.00187	CcSEcCtD
Rilpivirine—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000249	0.00186	CcSEcCtD
Rilpivirine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000249	0.00186	CcSEcCtD
Rilpivirine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000248	0.00185	CcSEcCtD
Rilpivirine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000242	0.00181	CcSEcCtD
Rilpivirine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.0018	CcSEcCtD
Rilpivirine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000241	0.0018	CcSEcCtD
Rilpivirine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000241	0.0018	CcSEcCtD
Rilpivirine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000237	0.00178	CcSEcCtD
Rilpivirine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00177	CcSEcCtD
Rilpivirine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000236	0.00177	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000235	0.00176	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000235	0.00176	CcSEcCtD
Rilpivirine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000234	0.00175	CcSEcCtD
Rilpivirine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000232	0.00174	CcSEcCtD
Rilpivirine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000232	0.00174	CcSEcCtD
Rilpivirine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000232	0.00174	CcSEcCtD
Rilpivirine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.00173	CcSEcCtD
Rilpivirine—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.00173	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00023	0.00172	CcSEcCtD
Rilpivirine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00023	0.00172	CcSEcCtD
Rilpivirine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000227	0.0017	CcSEcCtD
Rilpivirine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000226	0.00169	CcSEcCtD
Rilpivirine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000225	0.00169	CcSEcCtD
Rilpivirine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000224	0.00167	CcSEcCtD
Rilpivirine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000224	0.00167	CcSEcCtD
Rilpivirine—Rash—Topotecan—peripheral nervous system neoplasm	0.000223	0.00167	CcSEcCtD
Rilpivirine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000223	0.00167	CcSEcCtD
Rilpivirine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000223	0.00167	CcSEcCtD
Rilpivirine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000223	0.00167	CcSEcCtD
Rilpivirine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00166	CcSEcCtD
Rilpivirine—Headache—Topotecan—peripheral nervous system neoplasm	0.000222	0.00166	CcSEcCtD
Rilpivirine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000222	0.00166	CcSEcCtD
Rilpivirine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000222	0.00166	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000222	0.00166	CcSEcCtD
Rilpivirine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000221	0.00166	CcSEcCtD
Rilpivirine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000221	0.00166	CcSEcCtD
Rilpivirine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000221	0.00166	CcSEcCtD
Rilpivirine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000221	0.00165	CcSEcCtD
Rilpivirine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000221	0.00165	CcSEcCtD
Rilpivirine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00022	0.00165	CcSEcCtD
Rilpivirine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00022	0.00165	CcSEcCtD
Rilpivirine—Rash—Melphalan—peripheral nervous system neoplasm	0.000219	0.00164	CcSEcCtD
Rilpivirine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000219	0.00164	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00163	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000215	0.00161	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000214	0.0016	CcSEcCtD
Rilpivirine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.00158	CcSEcCtD
Rilpivirine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000211	0.00157	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00021	0.00157	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00156	CcSEcCtD
Rilpivirine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000209	0.00156	CcSEcCtD
Rilpivirine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000209	0.00156	CcSEcCtD
Rilpivirine—Infection—Etoposide—peripheral nervous system neoplasm	0.000207	0.00155	CcSEcCtD
Rilpivirine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000206	0.00154	CcSEcCtD
Rilpivirine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000206	0.00154	CcSEcCtD
Rilpivirine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.00154	CcSEcCtD
Rilpivirine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000203	0.00152	CcSEcCtD
Rilpivirine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000202	0.00151	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00148	CcSEcCtD
Rilpivirine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000197	0.00148	CcSEcCtD
Rilpivirine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000197	0.00147	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000196	0.00147	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00145	CcSEcCtD
Rilpivirine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.00143	CcSEcCtD
Rilpivirine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000185	0.00138	CcSEcCtD
Rilpivirine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000184	0.00138	CcSEcCtD
Rilpivirine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000183	0.00137	CcSEcCtD
Rilpivirine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.00136	CcSEcCtD
Rilpivirine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000181	0.00136	CcSEcCtD
Rilpivirine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000181	0.00135	CcSEcCtD
Rilpivirine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00134	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00018	0.00134	CcSEcCtD
Rilpivirine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000179	0.00134	CcSEcCtD
Rilpivirine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.00132	CcSEcCtD
Rilpivirine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000176	0.00131	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00129	CcSEcCtD
Rilpivirine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000171	0.00128	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00017	0.00127	CcSEcCtD
Rilpivirine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00017	0.00127	CcSEcCtD
Rilpivirine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.00127	CcSEcCtD
Rilpivirine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.00126	CcSEcCtD
Rilpivirine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.00126	CcSEcCtD
Rilpivirine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.00125	CcSEcCtD
Rilpivirine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00124	CcSEcCtD
Rilpivirine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000164	0.00123	CcSEcCtD
Rilpivirine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000163	0.00122	CcSEcCtD
Rilpivirine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000163	0.00122	CcSEcCtD
Rilpivirine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00121	CcSEcCtD
Rilpivirine—Rash—Vincristine—peripheral nervous system neoplasm	0.000162	0.00121	CcSEcCtD
Rilpivirine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000162	0.00121	CcSEcCtD
Rilpivirine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000161	0.0012	CcSEcCtD
Rilpivirine—Headache—Vincristine—peripheral nervous system neoplasm	0.000161	0.0012	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.0012	CcSEcCtD
Rilpivirine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.00118	CcSEcCtD
Rilpivirine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000155	0.00116	CcSEcCtD
Rilpivirine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000152	0.00114	CcSEcCtD
Rilpivirine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00112	CcSEcCtD
Rilpivirine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000149	0.00112	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00111	CcSEcCtD
Rilpivirine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00111	CcSEcCtD
Rilpivirine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000144	0.00108	CcSEcCtD
Rilpivirine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00108	CcSEcCtD
Rilpivirine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000143	0.00107	CcSEcCtD
Rilpivirine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000143	0.00107	CcSEcCtD
Rilpivirine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00107	CcSEcCtD
Rilpivirine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000142	0.00106	CcSEcCtD
Rilpivirine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000138	0.00103	CcSEcCtD
Rilpivirine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00103	CcSEcCtD
Rilpivirine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000135	0.00101	CcSEcCtD
Rilpivirine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000995	CcSEcCtD
Rilpivirine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000132	0.000989	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000989	CcSEcCtD
Rilpivirine—Rash—Etoposide—peripheral nervous system neoplasm	0.000131	0.000981	CcSEcCtD
Rilpivirine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000131	0.00098	CcSEcCtD
Rilpivirine—Headache—Etoposide—peripheral nervous system neoplasm	0.00013	0.000975	CcSEcCtD
Rilpivirine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000124	0.000924	CcSEcCtD
Rilpivirine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000907	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000903	CcSEcCtD
Rilpivirine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00089	CcSEcCtD
Rilpivirine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000866	CcSEcCtD
Rilpivirine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000855	CcSEcCtD
Rilpivirine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000847	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000839	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000836	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000823	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000802	CcSEcCtD
Rilpivirine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000791	CcSEcCtD
Rilpivirine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000789	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000784	CcSEcCtD
Rilpivirine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000775	CcSEcCtD
Rilpivirine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000758	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000753	CcSEcCtD
Rilpivirine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000752	CcSEcCtD
Rilpivirine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.00073	CcSEcCtD
Rilpivirine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000717	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.000713	CcSEcCtD
Rilpivirine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000701	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.31e-05	0.000697	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.3e-05	0.000696	CcSEcCtD
Rilpivirine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000689	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	0.00066	CcSEcCtD
Rilpivirine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000638	CcSEcCtD
Rilpivirine—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.000626	CcSEcCtD
Rilpivirine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.000597	CcSEcCtD
Rilpivirine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000579	CcSEcCtD
Rilpivirine—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000577	CcSEcCtD
Rilpivirine—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000555	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.38e-05	0.000552	CcSEcCtD
Rilpivirine—Rash—Epirubicin—peripheral nervous system neoplasm	7.35e-05	0.00055	CcSEcCtD
Rilpivirine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000549	CcSEcCtD
Rilpivirine—Headache—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000546	CcSEcCtD
Rilpivirine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000534	CcSEcCtD
Rilpivirine—Nausea—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.000518	CcSEcCtD
Rilpivirine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000513	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—peripheral nervous system neoplasm	6.8e-05	0.000509	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.8e-05	0.000508	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000506	CcSEcCtD
Rilpivirine—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000479	CcSEcCtD
